__timestamp | Ascendis Pharma A/S | GSK plc |
---|---|---|
Wednesday, January 1, 2014 | 6274000 | 8246000000 |
Thursday, January 1, 2015 | 9415000 | 9232000000 |
Friday, January 1, 2016 | 11504000 | 9366000000 |
Sunday, January 1, 2017 | 13482000 | 9672000000 |
Monday, January 1, 2018 | 25057000 | 9915000000 |
Tuesday, January 1, 2019 | 48473000 | 11402000000 |
Wednesday, January 1, 2020 | 76669000 | 11456000000 |
Friday, January 1, 2021 | 160180000 | 10975000000 |
Saturday, January 1, 2022 | 221227000 | 8372000000 |
Sunday, January 1, 2023 | 264410000 | 9385000000 |
Monday, January 1, 2024 | 284545000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, GSK plc and Ascendis Pharma A/S have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. GSK, a stalwart in the industry, consistently reported SG&A expenses averaging around $9.8 billion annually, reflecting its expansive global operations. In contrast, Ascendis Pharma, a burgeoning biotech firm, saw its SG&A expenses skyrocket by over 4,000% from 2014 to 2023, highlighting its aggressive growth strategy.
By 2023, Ascendis Pharma's SG&A expenses reached approximately 2.6% of GSK's, a testament to its rapid expansion. This comparison underscores the diverse strategies employed by established giants and emerging innovators in managing operational costs. As the pharmaceutical sector continues to evolve, understanding these financial dynamics offers invaluable insights into corporate strategy and market positioning.
Johnson & Johnson or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Amgen Inc. vs GSK plc Trends and Insights
Breaking Down SG&A Expenses: GSK plc vs Biogen Inc.
SG&A Efficiency Analysis: Comparing GSK plc and Summit Therapeutics Inc.
Cost Management Insights: SG&A Expenses for GSK plc and MorphoSys AG
Selling, General, and Administrative Costs: GSK plc vs BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ascendis Pharma A/S and Alpine Immune Sciences, Inc.
Ascendis Pharma A/S vs Ultragenyx Pharmaceutical Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ascendis Pharma A/S vs Corcept Therapeutics Incorporated
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Perrigo Company plc
Ascendis Pharma A/S and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S and Vericel Corporation: SG&A Spending Patterns Compared